Results 1 to 10 of about 27,337 (100)
Progress of clinical therapies for dry age-related macular degeneration [PDF]
International Journal of Ophthalmology, 2022 Dry age-related macular degeneration (AMD) is a progressive blinding disease that currently affects millions of people worldwide with no successful treatment available.
Rhianna Rubner +2 more
doaj +1 more source
Dry age-related macular degeneration - therapeutic possibilities and research directions [PDF]
Farmacja Polska, 2022 Age-related macular degeneration (AMD) is a major cause of vision loss in developed countries, especially in the elderly population. AMD is a multifactorial disease which etiology is not completely understood.
Alicja Zajdel
doaj +1 more source
Sleep, Pain, and Neurodegeneration: A Mendelian Randomization Study
Frontiers in Neurology, 2022 Our aim was to determine whether the genetic liability to sleep and pain-related traits have a causal effect on risk of neurodegeneration in individuals of predominantly European ancestry. We selected five neurodegenerative disorders, namely, age-related
Sandeep Grover +2 more
doaj +1 more source
BMC Ophthalmology, 2023 Background The aim of this study was to describe features of disease activity in patients with treated stable macular neovascularisation (MNV) in neovascular age related macular degeneration (nAMD) using optical coherence tomography angiography (OCTA ...
Daren Hanumunthadu +6 more
doaj +1 more source
PLoS ONE, 2021 ObjectiveThis study aimed to investigate the risk of Alzheimer's disease among patients with age-related macular degeneration and its association with confounding comorbidities.MethodThis was a population-based, retrospective cohort study.
Li-Yen Wen +9 more
doaj +1 more source
Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model [PDF]
International Journal of Ophthalmology, 2014 AIM:To determine the involvement of the interleukin (IL)-6 with the development of experimental subretinal fibrosis in a mouse model.METHODS:Subretinal fibrosis was induced by subretinal injection of macrophage-rich peritoneal exudate cells and the local
Wei Cui, Han Zhang, Zhe-Li Liu
doaj +1 more source
Innate immune biology in age-related macular degeneration
Frontiers in Cell and Developmental Biology, 2023 Age-related macular degeneration (AMD) is a neurodegenerative disease and a leading cause of irreversible vision loss in the developed world. While not classically described as an inflammatory disease, a growing body of evidence has implicated several ...
Karina Ascunce +4 more
doaj +1 more source
Nanotechnology for Age-Related Macular Degeneration
Pharmaceutics, 2021 Age-related macular degeneration (AMD) is a degenerative eye disease that is the leading cause of irreversible vision loss in people 50 years and older.
Bo Yang +6 more
doaj +1 more source
Age-related macular degeneration: an overview
Revista Brasileira de Oftalmologia, 2021 Age-related macular degeneration is the most important cause of irreversible vision loss in the elderly and has been considered a severe public health problem. Current treatments have only been successful in delaying the loss of central vision.
Rogil José de Almeida Torres +1 more
doaj +1 more source
Age-Related Macular or Retinal Degeneration?
Medicina, 2023 Age-related macular degeneration (AMD) is an eye disease that leads to progressive vision loss. Its prevalence has been increasing due to population aging.
Michalina Gałuszka +2 more
doaj +1 more source